Hippocampal and thalamic neuronal metabolism in a putative rat model of schizophrenia

Neural Regeneration Research

Volumn 8, Issue 26, 2013, Pages 2415-2423

  Ma, Guo Lin ^a   Song, Tian Bin ^b   Chen, Min ^c   Fu, Yuan ^c   Xu, Yong ^d   Ma, En Sen ^a   Wang, Wu ^a   Du, Jiang ^e   Huang, Ming Xiong ^e  

^a CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^b Beijing Shunyi Hospital Affiliated to China Medical University   (China)

^c BEIJING HOSPITAL   (China)

^d SHANXI MEDICAL UNIVERSITY   (China)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Early growth response protein 3; Gene; Hippocampus; Neural regeneration; Neuroimaging; Neuroregeneration; Proton magnetic resonance spectroscopy; Schizophrenia; Thalamus

Indexed keywords

CHOLINE; CREATINE; CREATINE PHOSPHATE; EARLY GROWTH RESPONSE FACTOR 1; LENTIVIRUS VECTOR; N ACETYLASPARTIC ACID; RISPERIDONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DENTATE GYRUS; GENETIC TRANSFECTION; HIPPOCAMPUS; MALE; MAZE TEST; METABOLISM; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; SCHIZOPHRENIA; SPATIAL MEMORY; THALAMUS; WORKING MEMORY;

EID: 84888383676     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.3969/j.issn.1673-5374.2013.26.002     Document Type: Article

References (47)

1. Sablier J, Stip E, Franck N. Cognitive remediation and cognitive assistive technologies in schizophrenia. Ence-phale. 2009,35(2):160-167.
2. Zhang YL. Textbook of Advanced Psychiatry. Changsha, China: Central South University Press. 2007.
3. Tsuang MT, Gilbertson MW, Faraone SV. The genetics of schizophrenia. Current knowledge and future. Directions. Schizophr Res. 1991;4(2):157-171.
4. O'Donovan KJ, Tourtellotte W G, Millbrandt J, et al. The EGR family of transcription-regulatory factors: progress at the interface of molecular and systems neuroscience. Trends Neurosci. 1999;22(4):167-173.
5. Eldredge LC, Gao XM, Quach DH, et al. Abnormal sym- pathetic nervous system development and physiological dysautonomia in Egr3-deficient mice. Development. 2008; 135(18):2949-2957.
6. Roberts DS, Hu Y, Lund IV, et al. Brain-derived neuro-trophic factor (BDNF)-induced synthesis of early growth response factor 3 (Egr3) controls the levels of type A GABA receptor alpha 4 subunits in hippocampal neurons. J Biol Chem. 2006;281(40):29431-29435.
7. Santos AR, Duarte CB. Validation of internal control genes for expression studies: effects of the neurotrophin BDNF on hippocampal neurons. J Neurosci Res. 008;86(16): 3684-3692.
8. Jacobson C, Duggan D, Fischbach G. Neuregulin induces the expression of transcription factors and myosin heavy chains typical of muscle spindles in cultured human mus- cle. Proc Natl Acad Sci U S A. 2004;101(33):12218-12223.
9. Calella AM, Nerlov C, Lopez RG, et al. Neurotrophin/Trk receptor signaling mediates C/EBPalpha, -beta and Neu-roD recruitment to immediate-early gene promoters in neuronal cells and requires C/EBPs to induce immediate-early gene transcription. Neural Dev. 2007:2:4.
10. Ehrengruber MU, Muhlebach SG, Sohrman S, et al. Modulation of early growth response (EGR) transcription factor-dependent gene expression by using recombinant adenovirus. Gene. 2000;258(1-2):63-69.
11. Gao X, Daugherty RL, Tourtellotte W G. Regulation of low affinity neurotrophin receptor (p75(NTR)) by early growth response (Egr) transcriptional regulators. Mol Cell Neu-rosci. 2007;36(4):501-514.
12. Dechant G, Barde YA. The neurotrophin receptor p75(NTR): novel functions and implications for diseases of the nervous system. Nat Neurosci. 2002;5(11):1131-1136.
13. Nguyen T, Di Giovanni S. NFAT signaling in neural development and axon growth. Int J Dev Neurosci. 2008;26(2):141-145.
14. Graef IA, Wang F, Charron F, et al. Neurotrophins and netrins require calcineurin/NFAT signaling to stimulate outgrowth of embryonic axons. Cell. 2003;113(5):657-670.
15. Rengarajan J, Mittelstadt PR, Mages HW, et al. Sequential involvement of NFAT and Egr transcription factors in FasL regulation. Immunity. 2000;12(3):293-300.
16. Mexal S, Frank M, Berger R, et al. Differential modulation of gene expression in the NMDA postsynaptic density of schizophrenic and control smokers. Brain Res Mol Brain Res. 2005;139(2):317-332.
17. Yamada K, Gerber DJ, Iwayama Y, et al. Genetic analysis of the calcineurin pathway identifies members of the EGR gene family, specifically EGR3, as potential susceptibility candidates in schizophrenia. Proc Natl Acad Sci U S A. 2007;104(8):2815-2820.
18. Gerber DJ, Hall D, Miyakawa T, et al. Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit. Proc Natl Acad Sci USA. 2003;100(15):8993-8998.
19. Gallitano-Mendel A, Wozniak DF, Pehek EA, et al. Mice lacking the immediate early gene Egr3 respond to the anti-aggressive effects of clozapine yet are relatively resistant to its sedating effects. Neuropsychopharmacology. 2008;33(6):1266-1275.
20. Cheng MC, Chuang YA, Lu CL, et al. Genetic and functional analyses of early growth response (EGR) family genes in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2012;39(1):149-155.
21. DeLeon A, Patel NC, Crismon ML. Aripiprazole: A comprehensive review of its pharmacology, clinical efficacy, and tolerability. Clin Ther. 2004;(26):649-666.
22. 1H-MRS at 4 Tesla in minimally treated early schizophrenia. Mol Psychiatry. 2010;15(6):629-636.
23. 1H-MRS findings and clinical symptoms in patients with schizophrenia. Zhongguo Shenjing Jingshen Jibing Zazhi. 2009;35(6):359-362.
24. Pegues MP, Rogers LJ, Amend D, et al. Anterior hippo-campal volume reduction in male patients with schizophrenia. Schizophr Res. 2003;60(2-3):105-115.
25. Szulc A, Galifiska B, Tarasow E, et al. The influence of atypical antipsychotics on brain functioning in schizophrenia. A proton magnetic resonance study. Psychiatr Pol. 2010;44(3):415-426.
26. Wang F, Sun ZG, Ruan Y, et al. A H1- magnetic resonance spectroscopy imaging study on hippocampus in male patients with schizophrenia. Zhonghua Shenjngke Zazhi. 2004;37(2):78-80.
27. Chen LJ, Xie SP, Chen N. A proton magnetic resonance spectroscopy on frontal lobe in the first-episode male schizophrenic patients. Shanghai Shenjing Yixue. 2006; 2(18):88-90.
28. Hajek T, Bauer M, Pfennig A, et al. Large positive effect of lithium on prefrontal cortex N-acetylaspartate in patients with bipolar disorder: 2-centre study. J Psychiatry Neu-rosci. 2012;37(3):185-192.
29. Chiu CT, Wang Z, Hunsberger JG, et al. Therapeutic potential of mood stabilizers lithium and valproic Acid: beyond bipolar disorder. Pharmacol Rev. 2013;65(1): 105-142.
30. Lehtimäki KK, Valonen PK, Griffin JL, et al. Metabolite changes in BT4C rat gliomas undergoing ganciclo-vir-thymidine kinase gene therapy-induced programmed cell death as studied by 1H-NMR spectroscopy in vivo, ex vivo, and in vitro. J Biol Chem. 2003;278(46): 45915-45923.
31. Mirbahai L, Wilson M, Shaw CS, et al. Lipid biomarkers of glioma cell growth arrest and cell death detected by 1 H magic angle spinning MRS. NMR Biomed. 2012;25(11): 1253-1262.
32. McKnight TR, Smith KJ, Chu PW, et al. Choline metabolism, proliferation, and angiogenesis in nonenhancing grades 2 and 3 astrocytoma. J Magn Reson Imaging. 2011;33(4):808-816.
33. Marchan R, Lesjak MS, Stewart JD. Choline-releasing glycerophosphodiesterase EDI3 links the tumor metabo-lome to signaling network activities. Cell Cycle. 2012:11(24):4499-506.
34. Matsumoto H, Simmons A, Williams S, et al. Structural magnetic imaging of the hippocampus in early onset schizophrenia. Biol Psychiatry. 2001;49(10):824-831.
35. De Peri L, Crescini A, Deste G, et al. Brain structural abnormalities at the onset of schizophrenia and bipolar disorder: a meta-analysis of controlled magnetic resonance imaging studies. Curr Pharm Des. 2012;18(4):486-494.
36. Juuhl-Langseth M, Rimol LM, Rasmussen IA Jr, et al. Comprehensive segmentation of subcortical brain volumes in early onset schizophrenia reveals limited structural abnormalities. Psychiatry Res. 2012;30;203(1):14-23.
37. Gan JL, Duan HF, Yang JM, et al. 1H-MRS study of prefrontal lobe and thalamus in male patients with schizophrenia. Zhongguo Yixue Yingxiang Jishu. 2009;25(7): 1152-1155.
38. Reid MA, Stoeckel LE, White DM, et al. Assessments of function and biochemistry of the anterior cingulate cortex in schizophrenia. Biol Psychiatry. 2010;68(7):625-633.
39. Ohrmann P, Siegmund A, Suslow T, et al. Cognitive impairment and in vivo metabolites in first-episode neuro-leptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study. J Psy-chiatr Res. 2007;41(8):625-634.
40. Egerton A, Stone JM. The glutamate hypothesis of schizophrenia: neuroimaging and drug development. Curr Pharm Biotechnol. 2012; 13(8): 1500-1512.
41. Kraguljac NV, Reid M, White D, et al. Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis. Psychiatry Res. 2012; 203(2-3):111-125.
42. Kegeles LS, Mao X, Stanford AD, et al. Elevated prefrontal cortex gamma-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy. Arch Gen Psychiatry. 2012;69(5):449-459.
43. Francis LS, Robin AH, Katherine HT, et al. Anterior cingulate cortex: unique role in cognition and emotion. J Neuropsychiatry Clin Neurosci. 2011;23(2):121-125.
44. Port JD, Agarwal N. MR spectroscopy in schizophrenia. J Magn Reson Imaging. 2011;34(6):1251-1261.
45. The Ministry of Science and Technology of the People's Republic of China. Guidance Suggestions for the Care and Use of Laboratory Animals. 2006-09-30.
46. Omata N, Chiu CT, Moya PR, et al. Lentivirally mediated GSK-3β silencing in the hippocampal DG induces antide-pressant-like effects in stressed mice. Int J Neuropsy-chopharmacol. 2011;14(5):711-717.
47. Zhang K, Song X, Xu Y, et al. Continuous GSK-3β over-expression in the hippocampal dentate gyrus induces prodepressant-like effects and increases sensitivity to chronic mild stress in mice. J Affect Disord. 2013;146(1): 45-52.